These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 29038348

  • 1. STK33 Promotes Growth and Progression of Pancreatic Cancer as a Critical Downstream Mediator of HIF1α.
    Kong F, Kong X, Du Y, Chen Y, Deng X, Zhu J, Du J, Li L, Jia Z, Xie D, Li Z, Xie K.
    Cancer Res; 2017 Dec 15; 77(24):6851-6862. PubMed ID: 29038348
    [Abstract] [Full Text] [Related]

  • 2. Citron Rho-Interacting Serine/Threonine Kinase Promotes HIF1a-CypA Signaling and Growth of Human Pancreatic Adenocarcinoma.
    Cong L, Bai Z, Du Y, Cheng Y.
    Biomed Res Int; 2020 Dec 15; 2020():9210891. PubMed ID: 32185224
    [Abstract] [Full Text] [Related]

  • 3. LASP1 is a HIF1α target gene critical for metastasis of pancreatic cancer.
    Zhao T, Ren H, Li J, Chen J, Zhang H, Xin W, Sun Y, Sun L, Yang Y, Sun J, Wang X, Gao S, Huang C, Zhang H, Yang S, Hao J.
    Cancer Res; 2015 Jan 01; 75(1):111-9. PubMed ID: 25385028
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.
    Maity G, Haque I, Ghosh A, Dhar G, Gupta V, Sarkar S, Azeem I, McGregor D, Choudhary A, Campbell DR, Kambhampati S, Banerjee SK, Banerjee S.
    J Biol Chem; 2018 Mar 23; 293(12):4334-4349. PubMed ID: 29414775
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. MicroRNA-224 Promotes Pancreatic Cancer Cell Proliferation and Migration by Targeting the TXNIP-Mediated HIF1α Pathway.
    Zhu G, Zhou L, Liu H, Shan Y, Zhang X.
    Cell Physiol Biochem; 2018 Mar 23; 48(4):1735-1746. PubMed ID: 30078003
    [Abstract] [Full Text] [Related]

  • 12. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.
    Chang W, Liu M, Xu J, Fu H, Zhou B, Yuan T, Chen P.
    Tumour Biol; 2016 Nov 23; 37(11):14813-14824. PubMed ID: 27638830
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity.
    Liang E, Lu Y, Shi Y, Zhou Q, Zhi F.
    Oncogene; 2020 Oct 23; 39(41):6437-6450. PubMed ID: 32879444
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5.
    Zeeh F, Witte D, Gädeken T, Rauch BH, Grage-Griebenow E, Leinung N, Fromm SJ, Stölting S, Mihara K, Kaufmann R, Settmacher U, Lehnert H, Hollenberg MD, Ungefroren H.
    Oncotarget; 2016 Jul 05; 7(27):41095-41109. PubMed ID: 27248167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.